Nucleotide sequence-based typing of meningococci directly from clinical samples

Journal of Medical Microbiology

Volumn 52, Issue 6, 2003, Pages 505-508

  Diggle, Mathew A ^a   Bell, Carolyn M ^a   Clarke, Stuart C ^a,b  

^a STOBHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; PRIMER DNA; PRIMER RNA;

ANALYTIC METHOD; ANXIETY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD GROUP TYPING; CONJUGATE; DIAGNOSTIC ACCURACY; HUMAN; INFORMATION; MENINGOCOCCOSIS; MICROORGANISM; MOLECULAR BIOLOGY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROBABILITY; REPRODUCIBILITY; SAMPLE;

DISEASE OUTBREAKS; DNA PRIMERS; DNA, BACTERIAL; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; SCOTLAND; SEQUENCE ANALYSIS, DNA;

EID: 0038772019     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05078-0     Document Type: Article

References (28)

1. Cartwright, K., Reilly, S., White, D. & Stuart, J. (1992). Early treatment with parenteral penicillin in meningococcal disease. BMJ 305, 143-147.
2. Cartwright, K., Noah, N. & Peltola, H. (2001). Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine 19, 4347-4356.
3. Clarke, S. C. & Diggle, M. A. (2002). Automated PCR/sequence template purification. Mol Biotechnol 21, 221-224.
4. Clarke, S. C. & Edwards, G. F. (2000). Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine. Scott Med J 45, 67.
5. Clarke, S. C., Christie, P. & Edwards, G. F. (1999). Enhanced surveillance of meningococcal disease in Scotland. SCIEH Wkly Rep 33, 235-236.
6. Clarke, S. C., Diggle, M. A. & Edwards, G. F. (2001a). Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J Clin Microbiol 39, 3066-3071.
7. Clarke, S. C., Reid, J., Thom, L., Denham, B. C. & Edwards, G. F. (2001b). Meningococcal disease due to serogroup Y in Scotland, 1992-1999. Br J Biomed Sci 58, 17-19.
8. Clarke, S. C., Diggle, M. A. & Edwards, G. F. (2001c). Automated non-culture-based sequence typing of meningococci from body fluids. Br J Biomed Sci 58, 230-234.
9. Clarke, S. C., Diggle, M. A., Reid, J. A., Thom, L. & Edwards, G. F. (2001d). Introduction of an automated service for the laboratory confirmation of meningococcal disease in Scotland. J Clin Pathol 54, 556-557.
10. Clarke, S. C., Reid, J., Thom, L., Denham, B. C. & Edwards, G. F. (2002). Laboratory confirmation of meningococcal disease in Scotland, 1993-9. J Clin Pathol 55, 32-36.
11. Connolly, M. & Noah, N. (1999). Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect 122, 41-49.
12. Diggle, M. A. & Clarke, S. C. (2002a). What a load of old sequence!!! J Clin Microbiol 40, 2707.
13. Diggle, M. A. & Clarke, S. C. (2002b). Rapid assignment of nucleotide sequence data to allele types for multi-locus sequence analysis (MLSA) of bacteria using an adapted database and modified alignment program. J Mol Microbiol Biotechnol 4, 515-517.
14. Diggle, M. A., Edwards, G. F. & Clarke, S. C. (2001a). Automation of fluorescence-based PCR for confirmation of meningococcal disease. J Clin Microbiol 39, 4518-4519.
15. Diggle, M. A., Edwards, G. F. S. & Clarke, S. C. (2001b). Developments in the diagnosis of meningococcal disease and the characterization of Neisseria meningitidis. Rev Med Microbiol 12, 211-217.
16. Enright, M. C., Knox, K., Griffiths, D., Crook, D. W. & Spratt, B. G. (2000). Molecular typing of bacteria directly from cerebrospinal fluid. Eur J Clin Microbiol Infect Dis 19, 627-630.
17. Feavers, I. M., Gray, S. J., Urwin, R., Russell, J. E., Bygraves, J. A., Kaczmarski, E. B. & Maiden, M. C. (1999). Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J Clin Microbiol 37, 3883-3887.
18. Guiver, M., Borrow, R., Marsh, J., Gray, S. J., Kaczmarski, E. B., Howells, D., Boseley, P. & Fox, A. J. (2000). Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 28, 173-179.
19. Harrison, L. H. (1995). The worldwide prevention of meningococcal infection. Still an elusive goal. JAMA 273, 419-421.
20. Hart, C. A. & Cuevas, L. E. (1997). Meningococcal disease in Africa. Ann Trop Med Parasitol 91, 777-785.
21. Kaczmarski, E. B., Ragunathan, P. L., Marsh, J., Gray, S. J. & Guiver, M. (1998). Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health 1, 54-56.
22. Kyaw, M. H., Clarke, S. C., Christie, P., Jones, I. G. & Campbell, H. (2002). Invasive meningococcal disease in Scotland, 1994 to 1999, with emphasis on group B meningococcal disease. J Clin Microbiol 40, 1834-1837.
23. Maiden, M. C. & Spratt, B. G. (1999). Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet 354, 615-616.
24. Newcombe, J., Cartwright, K., Palmer, W. H. & McFadden, J. (1996). PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 34, 1637-1640.
25. Ritchie, L. D. (2001). Meningococcal Group C Immunisation Programme in Scotland: Final Report. Glasgow: Meningococcal Group C Programme - Implementation Group.
26. Salisbury, D. (2001). Meningococcal group C vaccine and the United Kingdom experience. Int J Clin Pract Suppl, 10-11.
27. Virji, M. (1996). Meningococcai disease: epidemiology and pathogenesis. Trends Microbiol 4, 466-469.
28. Whalen, C. M., Hockin, J. C., Ryan, A. & Ashton, F. (1995). The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 273, 390-394.